Shilpa Medicare's Recent Gains Highlight Resilience Amid Broader Market Challenges

Shilpa Medicare, a midcap player in the Pharmaceuticals & Drugs industry, has shown notable activity today, gaining 5.37% on April 24, 2025. The stock has outperformed its sector by 3.98%, marking its third consecutive day of gains, with a total increase of 8.69% over this period. During intraday trading, Shilpa Medicare reached a high of Rs 718.
In terms of moving averages, the stock is currently above its 5-day, 20-day, and 50-day moving averages, although it remains below the 100-day and 200-day moving averages. This performance comes amid a broader market context where the Sensex is experiencing a slight decline of 0.24% after a flat opening.

Over the past week, Shilpa Medicare has delivered a return of 7.73%, outperforming the Sensex's 1.75% gain. However, its performance over the last three months shows a decline of 9.73%, contrasting with the Sensex's increase of 4.90%. Year-to-date, the stock has seen a decrease of 12.06%, while its one-year performance stands at a robust 34.61%, significantly outpacing the Sensex's 8.22% increase.